Telus Ventures has led a $47m round for the flexible workplace benefits platform that included existing backer Royal Bank of Canada.

Stanford spinout Toma Biosciences has created a genomics testing platform for classifying cancerous tumours according to their genetic mutations.

Bristol-Myers Squibb has put its weight behind IFM Tre, a spinoff of subsidiary IFM Therapeutics that has launched with $31m in series A funding.

Hepalink-backed Aridis Pharmaceuticals has filed to raise up to $34.5m that will support clinical trials for three immunotherapy drug candidates.

Concord Medical's radiotherapy-focused spinoff has raised new funding from investors including a China Electronics Corporation Data-owned fund.

Comcast Ventures was among the investors that put up $12.5m of financing for the care advice app developer.

The Johns Hopkins-backed antibody developer floated above its range and has seen its stock almost double in price.

The UC Investment Office-backed cancer drug developer cut the number of shares in the offering but priced them at the mid-point of its range.

The SR One-backed cancer drug developer cut the number of shares in the offering but priced them at the mid-point of its range.